ATE60999T1 - Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension. - Google Patents

Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.

Info

Publication number: ATE60999T1
Authority: AT; Austria
Prior art keywords: stabilized; suspension containing; dimethyldioctadecylammonium bromide; adjuvant; adjuvant suspension
Prior art date: 1986-12-19

Application number

AT87202523T

Other languages

English (en)

Inventor

Lucas Alfonsus Theodor Hilgers

Marinus Wijnand Weststrate

Original Assignee

Duphar Int Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-19

Filing date

1987-12-15

Publication date

1991-03-15

1987-12-15 Application filed by Duphar Int Res filed Critical Duphar Int Res

1991-03-15 Application granted granted Critical

1991-03-15 Publication of ATE60999T1 publication Critical patent/ATE60999T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

AT87202523T 1986-12-19 1987-12-15 Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension. ATE60999T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NL8603232		1986-12-19
EP87202523A EP0273512B1 (de)	1986-12-19	1987-12-15	Dimethyldioctadecylammoniumbromid enthaltende stabilisierte Adjuvanssuspension

Publications (1)

Publication Number	Publication Date
ATE60999T1 true ATE60999T1 (de)	1991-03-15

Family

ID=19849021

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87202523T ATE60999T1 (de)	1986-12-19	1987-12-15	Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.

Country Status (11)

Country	Link
US (1)	US5026546A (de)
EP (1)	EP0273512B1 (de)
JP (1)	JPS63165329A (de)
AT (1)	ATE60999T1 (de)
DE (1)	DE3768232D1 (de)
DK (1)	DK661387A (de)
ES (1)	ES2037072T3 (de)
GR (1)	GR3001527T3 (de)
IE (1)	IE60698B1 (de)
NZ (1)	NZ222938A (de)
PT (1)	PT86376B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2067624T3 (es) *	1989-11-16	1995-04-01	Ph & T S R L	Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.
NZ239643A (en) *	1990-09-17	1996-05-28	North American Vaccine Inc	Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
IL105325A (en) *	1992-04-16	1996-11-14	Minnesota Mining & Mfg	Immunogen/vaccine adjuvant composition
US6991797B2 (en) *	1993-07-02	2006-01-31	Statens Serum Institut	M. tuberculosis antigens
US5955077A (en) *	1993-07-02	1999-09-21	Statens Seruminstitut	Tuberculosis vaccine
BE1008977A5 (fr) *	1994-12-27	1996-10-01	Solvay	Adjuvants pour vaccins.
US6982085B2 (en) *	1997-04-02	2006-01-03	Statens Serum Institut	TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en)	1997-04-18	2006-05-02	Statens Serum Institut	Hybrids of M. tuberculosis antigens
US20040013685A1 (en) *	1997-11-10	2004-01-22	Peter Andersen	Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
FR2814957B1 (fr)	2000-10-06	2002-12-20	Aventis Pasteur	Composition vaccinale et procede de stabilisation
ATE533506T1 (de) *	2002-08-26	2011-12-15	Pfizer Prod Inc	Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei rindern
US6962608B1 (en)	2002-10-01	2005-11-08	The Regents Of The University Of California	Regenerable antimicrobial polymers and fibers with oxygen bleaches
ES2391770T3 (es)	2003-01-21	2012-11-29	Novartis Vaccines And Diagnostics, Inc.	Uso de compuestos de triptantrina para la potenciación inmune
ES2423800T3 (es)	2003-03-28	2013-09-24	Novartis Vaccines And Diagnostics, Inc.	Uso de compuestos orgánicos para la inmunopotenciación
EP1765313A2 (de)	2004-06-24	2007-03-28	Novartis Vaccines and Diagnostics, Inc.	Verbindungen als immunstimulatoren
CA2571710A1 (en)	2004-06-24	2006-11-02	Nicholas Valiante	Small molecule immunopotentiators and assays for their detection
US7749520B2 (en) *	2004-07-07	2010-07-06	Statens Serum Institut	Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
ITBO20050363A1 (it)	2005-05-26	2006-11-27	Maccaferri Spa Off	Elemento leggero di protezione filtro del tipo a materasso
CA2646539A1 (en) *	2006-03-23	2007-09-27	Novartis Ag	Imidazoquinoxaline compounds as immunomodulators
US20100010217A1 (en) *	2006-03-23	2010-01-14	Valiante Nicholas M	Methods for the preparation of imidazole-containing compounds
WO2007109812A2 (en) *	2006-03-23	2007-09-27	Novartis Ag	Immunopotentiating compounds
CL2008001806A1 (es) *	2007-06-20	2008-09-05	Wyeth Corp	Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
MX349720B (es)	2008-06-27	2017-08-09	Zoetis Services Llc	Composiciones adyuvantes novedosas.
JP5600116B2 (ja)	2008-12-09	2014-10-01	ギリアードサイエンシーズ，インコーポレイテッド	Ｔｏｌｌ様受容体のモジュレーター
WO2015042423A2 (en)	2013-09-19	2015-03-26	Zoetis Llc	Vaccine
WO2016001907A1 (en)	2014-07-02	2016-01-07	Prendergast Patrick T	Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
CN115317600A (zh)	2015-01-16	2022-11-11	硕腾服务有限责任公司	***疫苗
JP7339285B2 (ja)	2018-06-04	2023-09-05	アプロスセラピューティクス，インコーポレイテッド	Ｔｌｒ７ペプチドコンジュゲート
CA3103503A1 (en)	2018-07-02	2020-01-09	Ayuvis Research, Inc.	Novel immunodulating small molecules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3919411A (en) *	1972-01-31	1975-11-11	Bayvet Corp	Injectable adjuvant and compositions including such adjuvant

1987
- 1987-12-15 ES ES198787202523T patent/ES2037072T3/es not_active Expired - Lifetime
- 1987-12-15 EP EP87202523A patent/EP0273512B1/de not_active Expired
- 1987-12-15 AT AT87202523T patent/ATE60999T1/de not_active IP Right Cessation
- 1987-12-15 DE DE8787202523T patent/DE3768232D1/de not_active Expired - Fee Related
- 1987-12-16 IE IE340787A patent/IE60698B1/en not_active IP Right Cessation
- 1987-12-16 PT PT86376A patent/PT86376B/pt unknown
- 1987-12-16 NZ NZ222938A patent/NZ222938A/en unknown
- 1987-12-16 DK DK661387A patent/DK661387A/da not_active Application Discontinuation
- 1987-12-17 US US07/134,046 patent/US5026546A/en not_active Expired - Lifetime
- 1987-12-17 JP JP62317662A patent/JPS63165329A/ja active Pending
1991
- 1991-02-28 GR GR91400170T patent/GR3001527T3/el unknown

Also Published As

Publication number	Publication date
IE873407L (en)	1988-06-19
EP0273512A2 (de)	1988-07-06
GR3001527T3 (en)	1992-11-23
PT86376B (pt)	1990-11-20
DK661387D0 (da)	1987-12-16
NZ222938A (en)	1990-11-27
ES2037072T3 (es)	1993-06-16
JPS63165329A (ja)	1988-07-08
DK661387A (da)	1988-06-20
PT86376A (en)	1988-01-01
IE60698B1 (en)	1994-08-10
EP0273512A3 (en)	1988-07-27
EP0273512B1 (de)	1991-02-27
DE3768232D1 (de)	1991-04-04
US5026546A (en)	1991-06-25

Similar Documents

Publication	Publication Date	Title
ATE60999T1 (de)	1991-03-15	Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.
PT625053E (pt)	2002-09-30	Vacina a base de urease contra a infeccao por helicobacter
DE3751811T2 (de)	1996-11-28	LH-RH-Analoga enthaltende Formulierungen
DK407587D0 (da)	1987-08-05	Transdermalt indgivelsessystem
DE3582118D1 (de)	1991-04-18	Waessrige emulsion eines acrylsaeurecopolymer.
MX166713B (es)	1993-01-29	Polimerizacion catalizada por oxianion
ATE93387T1 (de)	1993-09-15	Stabilisierung von vesikeln.
FI873083A0 (fi)	1987-07-13	Foerfarande foer odling av bordetella pertussis, kikhostatoxoid och kikhostavaccin.
IT1116840B (it)	1986-02-10	Perfezionamento nelle composizioni farmaceutiche contenenti prostaglandina
BE886453A (fr)	1981-06-02	Compositions durcissables par l'oxygene comprenant un mercapto-organosiloxane, un compose fer-carbonyle et un acide
PT80740A (fr)	1985-10-01	Procede de preparation d'une composition de mouillage a base de fluorochlorohydrocarbure de tensioactif et d'acide carboxyli que
SU575022A3 (ru)	1977-09-30	Способ получени четвертичных аммониевых солей -диэтиламинопропил- -(2 инданил) -анилина
AU1081283A (en)	1983-08-18	Ozone inactivated organisms as vaccines
GR880100854A (el)	1994-03-31	Υδατικές διαμορφώσεις που περιέχουν ενα παράγωγο πιπεριδινυλκυκλοπεντυλεπτενοικού οξέος.
MY101764A (en)	1992-01-17	Ammonium salts of polymeric acids their preparation and use as fungicides.
ATE72401T1 (de)	1992-02-15	Impfstoff des klebsiella kapsulpolysaccharids.
ATE64852T1 (de)	1991-07-15	Stabile 5-fluorouracil-formulierungen.
PL267050A1 (en)	1989-03-20	Pesticide
ATE52160T1 (de)	1990-05-15	Ethyl-n'-(methoxy(methylthio)phosphinyl)-n,ndimethyl-carbamidothioat.
ATE69137T1 (de)	1991-11-15	Stabilisiertes gossyplure und verfahren zu dessen herstellung.
UA24024C2 (uk)	1998-08-31	Вакциhа ротавірусhа іhактивоваhа для імуhізації твариh
SE7804124L (sv)	1979-10-13	Vaccinstabiliseringsmedel

Legal Events

Date	Code	Title	Description
2008-03-15	EELA	Cancelled due to lapse of time